Scientists directly target cancer cells

新東方網>英語>英語學習>閱讀寫作>正文

Scientists directly target cancer cells

2007-05-11 11:18

來源：Reuters

作者：

SYDNEY- An Australian biotechnology firm said on Thursday it had developed a means of delivering anti-cancer drugs directly to cancer cells, which aims to avoid the debilitating toxicity associated with chemotherapy.

The method uses nanotechnology, which involves molecules far smaller than a human cell.

Pancreatic cancer cells are seen in an image courtesy of the National Cancer Institute. An Australian biotechnology firm said on Thursday it had developed a means of delivering anti-cancer drugs directly to cancer cells, which aims to avoid the debilitating toxicity associated with chemotherapy. [Reuters]

Direct targeting of chemotherapy drugs would allow dosages thousands of times lower than that in conventional chemotherapy and be more easily tolerated by patients, said the firm.

Writing in the May issue of U.S.-based Cancer Cell journal, the biotech firm EnGeneIC said it had developed nano-cells containing chemotherapy drugs.

Via antibodies on their surface, these nano-cells target and latch on to cancer cells. Once attached, the nano-cell is engulfed and the drug is released directly inside the cancer cell.

The firm said the bacterially derived nano-cell, called EnGeneIC delivery vehicles, had proven safe in primate trials and resulted in significant cancer regression.

It hoped to carry out human trials later in 2007 if it gained approval from Australian, U.S., European and Japanese regulatory authorities.

"For the first time there is a real possibility that this technology could lead to the use of multi-drug combinations and eventual custom-made therapies in cancer patients," research scientist Jennifer MacDiarmid said in a statement.

"In terms of tumor therapy, most late-stage cancer patients carry tumor cells that exhibit various forms of drug resistance. Our technology may provide the first in-vivo (inside an organism) solution to this serious hurdle."

（實習編輯：顧萍）

名稱名稱

300次下載

微信掃碼關注"新東方網"服務號

回復""立刻獲取！

版權及免責聲明

① 凡本網註明"稿件來源：新東方"的所有文字、圖片和音視頻稿件，版權均屬新東方教育科技集團（含本網和新東方網） 所有，任何媒體、網站或個人未經本網協議授權不得轉載、連結、轉貼或以其他任何方式複製、發表。已經本網協議授權的媒體、網站，在下載使用時必須註明"稿件來源：新東方"，違者本網將依法追究法律責任。

② 本網未註明"稿件來源：新東方"的文/圖等稿件均為轉載稿，本網轉載僅基於傳遞更多信息之目的，並不意味著贊同轉載稿的觀點或證實其內容的真實性。如其他媒體、網站或個人從本網下載使用，必須保留本網註明的"稿件來源"，並自負版權等法律責任。如擅自篡改為"稿件來源：新東方"，本網將依法追究法律責任。

③ 如本網轉載稿涉及版權等問題，請作者見稿後在兩周內速來電與新東方網聯繫，電話：[phone]。